[1]
Zamani, B., R., S. and A., E. 2018. Protective effect of carvedilol against anthracycline-induced cardiomyopathy on patients with breast cancer and lymphoma. International Journal of Advances in Medicine. 5, 1 (Jan. 2018), 16–20. DOI:https://doi.org/10.18203/2349-3933.ijam20180061.